A detailed history of Cibc World Market Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Cibc World Market Inc. holds 8,726 shares of CRSP stock, worth $433,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,726
Previous 11,364 23.21%
Holding current value
$433,856
Previous $534,000 35.77%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

SELL
$38.65 - $55.15 $101,958 - $145,485
-2,638 Reduced 23.21%
8,726 $343,000
Q3 2024

Nov 12, 2024

SELL
$44.62 - $62.75 $50,643 - $71,221
-1,135 Reduced 9.08%
11,364 $534,000
Q2 2024

Aug 07, 2024

SELL
$51.17 - $68.18 $39,759 - $52,975
-777 Reduced 5.85%
12,499 $675,000
Q1 2024

May 13, 2024

SELL
$60.67 - $89.12 $25,117 - $36,895
-414 Reduced 3.02%
13,276 $905,000
Q4 2023

Feb 13, 2024

BUY
$38.62 - $72.18 $132,814 - $248,227
3,439 Added 33.55%
13,690 $857,000
Q3 2023

Nov 13, 2023

BUY
$45.39 - $59.0 $49,702 - $64,605
1,095 Added 11.96%
10,251 $465,000
Q2 2023

Aug 11, 2023

SELL
$43.47 - $67.77 $8,607 - $13,418
-198 Reduced 2.12%
9,156 $514,000
Q1 2023

May 12, 2023

BUY
$41.0 - $56.12 $16,810 - $23,009
410 Added 4.58%
9,354 $423,000
Q4 2022

Feb 13, 2023

SELL
$39.19 - $65.67 $666 - $1,116
-17 Reduced 0.19%
8,944 $364,000
Q3 2022

Nov 10, 2022

SELL
$61.1 - $83.78 $25,478 - $34,936
-417 Reduced 4.45%
8,961 $586,000
Q2 2022

Aug 10, 2022

BUY
$43.23 - $73.83 $44,267 - $75,601
1,024 Added 12.26%
9,378 $570,000
Q1 2022

May 12, 2022

BUY
$53.19 - $79.24 $146,804 - $218,702
2,760 Added 49.34%
8,354 $524,000
Q4 2021

Feb 14, 2022

SELL
$70.09 - $111.29 $58,875 - $93,483
-840 Reduced 13.06%
5,594 $424,000
Q3 2021

Nov 12, 2021

SELL
$110.2 - $156.64 $577,888 - $821,420
-5,244 Reduced 44.9%
6,434 $720,000
Q2 2021

Aug 12, 2021

BUY
$100.84 - $161.89 $753,476 - $1.21 Million
7,472 Added 177.65%
11,678 $1.89 Million
Q1 2021

May 11, 2021

BUY
$110.72 - $210.04 $216,346 - $410,418
1,954 Added 86.77%
4,206 $513,000
Q4 2020

Feb 08, 2021

BUY
$79.67 - $173.23 $179,416 - $390,113
2,252 New
2,252 $345,000
Q3 2018

Nov 09, 2018

SELL
$44.35 - $65.71 $622,141 - $921,779
-14,028 Closed
0 $0
Q2 2018

Aug 08, 2018

SELL
$42.62 - $73.59 $480,327 - $829,359
-11,270 Reduced 44.55%
14,028 $824,000
Q1 2018

May 18, 2018

BUY
$23.52 - $58.17 $595,008 - $1.47 Million
25,298 New
25,298 $1.16 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.88B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.